Cargando…

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)

OBJECTIVES: During 2022, Omicron became the dominant SARS-CoV-2 variant in Europe. This study aims to assess the impact of such variant on severe disease from SARS-CoV-2 compared with the Delta variant in Italy. METHODS: Using surveillance data, we assessed the risk of developing severe COVID-19 wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrone, Daniele, Mateo-Urdiales, Alberto, Sacco, Chiara, Riccardo, Flavia, Bella, Antonino, Ambrosio, Luigina, Lo Presti, Alessandra, Di Martino, Angela, Ceccarelli, Emiliano, Del Manso, Martina, Fabiani, Massimo, Stefanelli, Paola, Pezzotti, Patrizio, Palamara, AnnaTeresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877142/ https://www.ncbi.nlm.nih.gov/pubmed/36708869 http://dx.doi.org/10.1016/j.ijid.2023.01.027

Ejemplares similares

Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
por: Fabiani, Massimo, et al.
Publicado: (2023)

Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
por: Fabiani, Massimo, et al.
Publicado: (2023)

Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2023)

Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021
por: Sacco, Chiara, et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study
por: Fabiani, Massimo, et al.
Publicado: (2023)

Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality
por: Marziano, Valentina, et al.
Publicado: (2023)

Socioeconomic patterns and COVID-19 outcomes before, during and after the lockdown in Italy (2020)
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy– Update on the 28th of March 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
por: Fabiani, Massimo, et al.
Publicado: (2021)

Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data
por: Fabiani, M., et al.
Publicado: (2022)

Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022
por: Liang, Yuelang, et al.
Publicado: (2022)

Geographic heterogeneity of the epidemiological impact of the COVID-19 pandemic in Italy using a socioeconomic proxy-based classification of the national territory
por: Petrelli, Alessio, et al.
Publicado: (2023)

Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy
por: Manica, Mattia, et al.
Publicado: (2021)

Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015–2018
por: Andrianou, Xanthi D., et al.
Publicado: (2021)

Timing and Magnitude of the Second Wave of the COVID-19 Omicron Variant — 189 Countries and Territories, November 2021 to February 2023
por: Niu, Beidi, et al.
Publicado: (2023)

Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020
por: Dorrucci, Maria, et al.
Publicado: (2021)

Avian influenza overview November 2019– February2020
por: Adlhoch, Cornelia, et al.
Publicado: (2020)

Avian influenza overview November 2017 ‐ February 2018
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Avian influenza overview November 2018 – February 2019
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy
por: Guzzetta, Giorgio, et al.
Publicado: (2021)

Assessing COVID-19-Related Excess Mortality Using Multiple Approaches—Italy, 2020–2021
por: Ceccarelli, Emiliano, et al.
Publicado: (2022)

A comparison of COVID-19 incidence rates across six European countries in 2021
por: Padget, Michael, et al.
Publicado: (2023)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)

Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system
por: Fabiani, Massimo, et al.
Publicado: (2021)

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
por: Baker, Julia M., et al.
Publicado: (2022)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
por: Lo Presti, Alessandra, et al.
Publicado: (2023)

Tracking the Selective Pressure Profile and Gene Flow of SARS-CoV-2 Delta Variant in Italy from April to October 2021 and Frequencies of Key Mutations from Three Representative Italian Regions
por: Lo Presti, Alessandra, et al.
Publicado: (2023)

A suite of 180 drawings, November 28, 1953-February 3, 1954
por: Picasso, Pablo, 1881-1973
Publicado: (1954)

Respiratory syncytial virus genotypes circulating in urban Ghana: february to november 2006
por: Obodai, Evangeline, et al.
Publicado: (2014)

Quarterly Report of the Edinburgh Surgical Hospital from November 1829 to February 1830
por: Syme, James
Publicado: (1830)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

COVID-19 response: effectiveness of weekly rapid risk assessments, Italy
por: Riccardo, Flavia, et al.
Publicado: (2022)

Obituary: Professor Ilya I. Blekhman (29 November 1928–03 February 2021)
por: Hedrih, Katica (Stevanović), et al.
Publicado: (2021)

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
por: Kim, Sara S., et al.
Publicado: (2022)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bqa6v3qbsrb9thu8ekd93ogds6